ahlam1399
09-04-2015, 02:21 AM
FDA approves expanded indication for AstraZeneca?s blood thinner
(Reuters) - AstraZeneca Plc said the U.S. Food and Drug Administration had approved a new dose of its blood thinner, Brilinta, for patients with a history of heart attack beyond the first year.
http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/1/rc.img (http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/2/rc.img (http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/3/rc.img (http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/3/rc.htm)
http://da.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/a2.img (http://da.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/a2.htm)
http://adchoice.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/ach.img (http://adchoice.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/ach.htm)http://pi.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/a2t.imghttp://pi2.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/498d6d2d/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=KjXEFS0CkOg:kO0l7J_xpP0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KjXEFS0CkOg:kO0l7J_xpP0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=KjXEFS0CkOg:kO0l7J_xpP0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KjXEFS0CkOg:kO0l7J_xpP0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=KjXEFS0CkOg:kO0l7J_xpP0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/KjXEFS0CkOg
(Reuters) - AstraZeneca Plc said the U.S. Food and Drug Administration had approved a new dose of its blood thinner, Brilinta, for patients with a history of heart attack beyond the first year.
http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/1/rc.img (http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/2/rc.img (http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/3/rc.img (http://rc.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/rc/3/rc.htm)
http://da.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/a2.img (http://da.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/a2.htm)
http://adchoice.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/ach.img (http://adchoice.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/ach.htm)http://pi.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/a2t.imghttp://pi2.feedsportal.com/r/238385160232/u/49/f/654207/c/35217/s/498d6d2d/sc/7/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/498d6d2d/sc/7/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=KjXEFS0CkOg:kO0l7J_xpP0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KjXEFS0CkOg:kO0l7J_xpP0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=KjXEFS0CkOg:kO0l7J_xpP0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=KjXEFS0CkOg:kO0l7J_xpP0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=KjXEFS0CkOg:kO0l7J_xpP0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/KjXEFS0CkOg